Sapiens International (SPNS) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 53,426.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 53,426.82% |
Regencell Bioscience (RGC) | 14,727.84% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,487.57% |
Cidara Therapeutics (CDTX) | 714.46% |
Celcuity LLC (CELC) | 665.2% |
Terns Pharmaceuticals (TERN) | 607.45% |
TMC the metals (TMC) | 592.11% |
Sandisk (SNDK) | 577.72% |
GRAIL, LLC (GRAL) | 411.17% |
Cogent Biosciences (COGT) | 400.63% |
Olema Pharmaceuticals (OLMA) | 371.79% |
Planet Labs PBC (PL) | 368.95% |
Aris Mining (ARMN) | 348.17% |
Aura Minerals Inc Common Shares (AUGO) | 342.91% |
Opendoor Technologies (OPEN) | 291.38% |
Centrus Energy (LEU) | 287.69% |
ViaSat (VSAT) | 284.2% |
Ondas (ONDS) | 268.8% |
DRDGOLD Limited ADR (DRD) | 261.51% |
Arrowhead Pharmaceuticals (ARWR) | 259.87% |
Applied Digital (APLD) | 254.78% |
Nuvation Bio (NUVB) | 252.24% |
New Gold (NGD) | 251.39% |
Praxis Precision Medicines (PRAX) | 251.16% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
